Synetic CareInsite IPO To Proceed Following Decision In Merck Litigation
Executive Summary
A New Jersey state court's denial of Merck's preliminary injunction request against Synetic has cleared the way for the company to proceed with a proposed spin-off of its health care e-commerce subsidiary CareInsite, Inc.
You may also be interested in...
Merck-Medco Management Transition Complete: Clark Succeeds Lofberg
Merck-Medco will be headed by a veteran Merck executive as the PBM division moves to a new level of prominence within the pharmaceutical company parent.
Merck-Medco Management Transition Complete: Clark Succeeds Lofberg
Merck-Medco will be headed by a veteran Merck executive as the PBM division moves to a new level of prominence within the pharmaceutical company parent.
Healtheon Paying $5 Bil. For CareInsite, Symbolic Role As New Medco
Healtheon/WebMD's acquisition of Medical Manager/CareInsite will allow Healtheon to inherit the image of the next Medco in the physician connectivity field.